🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this clinical trial is to assess the efficacy and safety of Infl...
Status
Completed
Location
Services Institute of Medical Sciences
Start Date
2022-10-01
Trial ID
NCT05663268
Treatments Being Tested
This is a post-marketing observational study of patients with Inflammatory ...
Status
Completed
Location
UZ Leuven Campus Gasthuisberg
Start Date
2015-04-22
Trial ID
NCT02539368
To collect information on the safety and effectiveness of Infliximab BS for...
Status
Completed
Location
Pfizer Local Country Office
Start Date
2019-03-18
Trial ID
NCT03884439
Treatments Being Tested
Participants maintaining stable disease activity of Ankylosing Spondylitis ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-01-15
Trial ID
NCT05164198
RABIOPRED is an in vitro non-invasive blood test, which aims to identify pa...
Status
Terminated
Location
Institute of Rheumatology
Start Date
2016-12
Trial ID
NCT03016260
Takayasu arteritis (TA) is a chronic inflammatory disease affecting large a...
Status
Unknown
Location
IRCCS Ospedale San Raffaele
Start Date
2017-03-01
Trial ID
NCT03192878
Treatments Being Tested
TNFα inhibitors have revolutionized the management of patients suffering fr...
Status
Completed
Location
Rheumatology Department, Cochin Hospital
Start Date
2023-02-24
Trial ID
NCT05424926
Treatments Being Tested
A study to describe the one-year persistence in participants treated by Fli...
Status
Completed
Location
Research Site
Start Date
2018-07-02
Trial ID
NCT03662919
Treatments Being Tested
The purpose of this observational study is to assess the safety and effecti...
Status
Completed
Location
Prince Hamza Hospital
Start Date
2017-03-23
Trial ID
NCT03348046
Treatments Being Tested
CT-P13 (Infliximab) is a monoclonal antibody currently being developed by C...
Status
Completed
Location
Hanyang University Medical Center
Start Date
2012-03
Trial ID
NCT01571219
Treatments Being Tested